Slate Medicines, Inc. · CIK 2117806
Slate Medicines, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Mar 11, 2026
through Mar 11, 2026
through Mar 11, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $130,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $9,999,992
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Imbria Pharmaceuticals, Inc. · CIK 1745672
- Lonestar Medicines, Inc. · CIK 2111460
- Pahr Therapeutics, Inc. · CIK 2077159
- Solstice Oncology, Inc. · CIK 2116600
- Superluminal Medicines, Inc. · CIK 1989478
Form D filings (1)
-
0001231919-26-000246D · Mar 11, 2026 · PharmaceuticalsOffering: $130,000,000Sold: $9,999,992